Creekside Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Sell
7,363
-852
-10% -$198K 0.74% 37
2025
Q4
$1.7M Buy
8,215
+22
+0.3% +$4.35K 0.72% 36
2025
Q3
$1.52M Buy
8,193
+27
+0.3% +$4.63K 0.67% 37
2025
Q2
$1.25M Buy
8,166
+22
+0.3% +$3.38K 0.59% 43
2025
Q1
$1.35M Buy
8,144
+29
+0.4% +$4.54K 0.71% 38
2024
Q4
$1.17M Buy
8,115
+29
+0.4% +$4.49K 0.61% 41
2024
Q3
$1.31M Sell
8,086
-34
-0.4% -$5.42K 0.68% 36
2024
Q2
$1.19M Buy
+8,120
New +$1.21M 0.66% 41

Other funds holding JNJ

Creekside Partners's JNJ Position: Q1 2026 in Review

Creekside Partners reduced its Johnson & Johnson (JNJ) stake by 10% in Q1 2026, selling an estimated $198K and leaving 7,363 shares worth $1.8M. The position accounts for 0.74% of the portfolio, ranked #37.

Creekside Partners first reported a position in JNJ in Q2 2024 and has held it in 8 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Creekside Partners held 7,363 shares of Johnson & Johnson worth $1.8M as of Q1 2026.
  • Creekside Partners sold 852 Johnson & Johnson shares in Q1 2026, an estimated $198K.
  • Johnson & Johnson made up 0.74% of Creekside Partners's portfolio in Q1 2026, its #37 holding.
  • Creekside Partners first reported a position in Johnson & Johnson in Q2 2024 and has held it in 8 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Creekside Partners's 13F filing for Q1 2026, filed 22 Apr 2026.